• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在使用来迪派韦/索磷布韦治疗丙型肝炎后,迟发性皮肤卟啉病中多个肝脏高回声结节消失。

Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.

作者信息

Takata Kazuhide, Shakado Satoshi, Sakamoto Keiko, Fukuda Hiromi, Yamauchi Ryo, Fukuda Sho, Kunimoto Hideo, Umeda Kaoru, Tanaka Takashi, Yokoyama Keiji, Morihara Daisuke, Takeyama Yasuaki, Irie Makoto, Sakisaka Shotaro

机构信息

Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, 7-45-1 Nanakuma, Jonan, Fukuoka, 814-0180, Japan.

Department of Radiology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.

出版信息

Clin J Gastroenterol. 2017 Oct;10(5):459-463. doi: 10.1007/s12328-017-0772-x. Epub 2017 Sep 7.

DOI:10.1007/s12328-017-0772-x
PMID:28884440
Abstract

Ultrasonography in a 60-year-old man with chronic hepatitis C (CHC) demonstrated multiple hyperechoic nodules. Radiological investigations did not reveal any signs of malignancy. However, magnetic resonance chemical shift imaging showed multiple focal fatty changes in the liver. Urinary levels of uroporphyrin and coproporphyrin were elevated, and we made a diagnosis of porphyria cutanea tarda. Direct-acting antivirals, ledipasvir/sofosbuvir, were initiated for CHC, which led to sustained viral response, resolution of the liver nodules, and normalization of urinary porphyrin. Hepatitis C virus infection can cause porphyria cutanea tarda with multiple hyperechoic liver nodules, which might be cured by direct-acting antivirals.

摘要

一名60岁慢性丙型肝炎(CHC)男性患者的超声检查显示有多个高回声结节。影像学检查未发现任何恶性迹象。然而,磁共振化学位移成像显示肝脏有多处局灶性脂肪变性。尿中尿卟啉和粪卟啉水平升高,我们诊断为迟发性皮肤卟啉症。开始使用直接抗病毒药物来迪派韦/索磷布韦治疗CHC,这导致了病毒持续应答、肝结节消退以及尿卟啉正常化。丙型肝炎病毒感染可导致伴有多个高回声肝结节的迟发性皮肤卟啉症,而直接抗病毒药物可能治愈该病。

相似文献

1
Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.在使用来迪派韦/索磷布韦治疗丙型肝炎后,迟发性皮肤卟啉病中多个肝脏高回声结节消失。
Clin J Gastroenterol. 2017 Oct;10(5):459-463. doi: 10.1007/s12328-017-0772-x. Epub 2017 Sep 7.
2
Anti-HCV for porphyria cutanea tarda.迟发性皮肤卟啉症的抗丙型肝炎病毒治疗
Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12466. Epub 2017 Jan 30.
3
Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.直接抗病毒(DAA)治疗后,迟发性皮肤卟啉症在HIV与丙型肝炎病毒(HCV)混合感染患者中的缓解情况。
J Antimicrob Chemother. 2017 Oct 1;72(10):2955-2958. doi: 10.1093/jac/dkx222.
4
Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.
JAMA Dermatol. 2016 Dec 1;152(12):1393-1395. doi: 10.1001/jamadermatol.2016.3036.
5
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.利迪帕韦/索磷布韦作为单独治疗伴有慢性丙型肝炎的迟发性皮肤卟啉症有效。
Dig Dis Sci. 2023 Jun;68(6):2738-2746. doi: 10.1007/s10620-023-07859-8. Epub 2023 Feb 22.
6
Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.索磷布韦/来迪帕司韦治疗一名4岁慢性丙型肝炎病毒1型感染儿童8周
Pediatr Infect Dis J. 2016 Dec;35(12):1373. doi: 10.1097/INF.0000000000001336.
7
Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.使用直接作用抗病毒药物治疗慢性丙型肝炎病毒感染后银屑病的缓解
Ann Intern Med. 2018 May 1;168(9):678-680. doi: 10.7326/L17-0613. Epub 2018 Jan 16.
8
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.雷迪帕韦和索非布韦联合利巴韦林治疗基因型 1 或 4 型丙型肝炎病毒感染和晚期肝病患者:一项多中心、开放标签、随机、2 期临床试验。
Lancet Infect Dis. 2016 Jun;16(6):685-697. doi: 10.1016/S1473-3099(16)00052-9. Epub 2016 Feb 18.
9
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.来迪派韦索磷布韦与利巴韦林联合治疗晚期肝病患者的 HCV 感染。
Gastroenterology. 2015 Sep;149(3):649-59. doi: 10.1053/j.gastro.2015.05.010. Epub 2015 May 15.
10
Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels.慢性丙型肝炎相关迟发性皮肤卟啉症的干扰素治疗无效,但丙型肝炎病毒RNA水平有短暂下降。
J Gastroenterol. 2000;35(1):60-2. doi: 10.1007/pl00009978.

引用本文的文献

1
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.利迪帕韦/索磷布韦作为单独治疗伴有慢性丙型肝炎的迟发性皮肤卟啉症有效。
Dig Dis Sci. 2023 Jun;68(6):2738-2746. doi: 10.1007/s10620-023-07859-8. Epub 2023 Feb 22.
2
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.迟发性皮肤卟啉病和肝红细胞生成性卟啉病:19 种新型尿卟啉原 III 脱羧酶突变的鉴定。
Mol Genet Metab. 2019 Nov;128(3):363-366. doi: 10.1016/j.ymgme.2018.11.013. Epub 2018 Nov 28.
3
Porphyria: What Is It and Who Should Be Evaluated?

本文引用的文献

1
Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda.丙型肝炎病毒直接作用抗病毒药物可迅速诱导迟发性皮肤卟啉症出现临床和生化缓解。
Br J Dermatol. 2017 Nov;177(5):e183-e184. doi: 10.1111/bjd.15502. Epub 2017 Sep 26.
2
Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.丙型肝炎病毒及其皮肤表现:直接作用抗病毒时代的治疗。
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1260-1270. doi: 10.1111/jdv.14186. Epub 2017 Mar 29.
3
A case of porphyria cutanea tarda of the liver exhibiting multifocal macrovesicular steatosis in the background of microvesicular steatosis, probably caused by uneven iron accumulation.
卟啉病:它是什么以及谁需要接受评估?
Rambam Maimonides Med J. 2018 Apr 19;9(2):e0013. doi: 10.5041/RMMJ.10333.
一例肝性迟发性皮肤卟啉症,背景为微泡性脂肪变性,存在多灶性大泡性脂肪变性,可能由铁不均匀沉积引起。
Abdom Radiol (NY). 2017 Jul;42(7):1813-1818. doi: 10.1007/s00261-017-1056-0.
4
Resolution of Porphyria Cutanea Tarda in Patients With Hepatitis C Following Ledipasvir-Sofosbuvir Combination Therapy.
JAMA Dermatol. 2016 Dec 1;152(12):1393-1395. doi: 10.1001/jamadermatol.2016.3036.
5
Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?治愈性抗病毒药物对丙型肝炎患者的迟发性皮肤卟啉症有益吗?
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e194. doi: 10.1111/jdv.13936. Epub 2016 Sep 16.
6
Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda.
Br J Dermatol. 2014 Dec;171(6):1595-6. doi: 10.1111/bjd.13376. Epub 2014 Sep 24.
7
Hepatitis C, porphyria cutanea tarda and liver iron: an update.丙型肝炎、迟发性皮肤卟啉病和肝铁:最新进展。
Liver Int. 2012 Jul;32(6):880-93. doi: 10.1111/j.1478-3231.2012.02794.x. Epub 2012 Apr 17.
8
Associations among behavior-related susceptibility factors in porphyria cutanea tarda.迟发性皮肤卟啉病相关易感性因素之间的关联。
Clin Gastroenterol Hepatol. 2010 Mar;8(3):297-302, 302.e1. doi: 10.1016/j.cgh.2009.11.017. Epub 2009 Nov 27.
9
The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
Cutis. 2006 Dec;78(6):397-400.
10
Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis.迟发性皮肤卟啉症中丙型肝炎病毒感染的患病率:系统评价和荟萃分析。
J Hepatol. 2003 Oct;39(4):620-7. doi: 10.1016/s0168-8278(03)00346-5.